AstraZeneca receives EU clearance for £27.5bn Alexion acquisition
The pharma giant is still waiting for the green light from the UK
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 21 of 55
Three-minute explainer: Getting to know your ADCs
Here we provide an intro to antibody-drug conjugates, the latest weapon in the fight against cancer
AstraZeneca says COVID-19 vaccine effective against Delta variant
Public Health England said the jab is 92% effective against hospitalisation from the strain
AstraZeneca receives EU approval for nerve cancer therapy for kids
It is the first time a drug for neurofibromatosis type 1 has been approved in the region
AstraZeneca wins legal battle with EU over COVID-19 vaccine deliveries
The pharma giant said a judge at the Court of First Instance in Brussels had ruled it had to supply 80.2mln doses by September 27, lower than the 120mln deamdned by the European Commission
Coronavirus: Delta variant has higher risk of hospitalisation in unvaccinated people, study shows
Two doses of a COVID-19 vaccine helped reduce the risk
AstraZeneca reports failure in COVID-19 antibody trial on people already exposed to virus
The candidate is also being studied as prevention in individuals not already infected, with results yet to be published
AstraZeneca to appoint new chief financial officer when Alexion acquisition completes
The group also posted positive results from a late-stage trial on its breast cancer candidate Lynparza
AstraZeneca receives EU approval for lung cancer drug Tagrisso
Tagrisso reduced the risk of disease recurrence or death by 80% in the overall trial population of patients
Arrow Global and Informa next in the firing line on executive pay after AstraZeneca furore
Après Soriot, le déluge? Institutional investors have been cutting up rough more than usual this year over executive pay, although they have yet to win a significant victory.
German scientists claim to know why AstraZeneca, Johnson & Johnson COVID-19 vaccines cause blood clots
The DNA-based formulations that have been linked to very rare cases of blood clots, some of which caused death
AstraZeneca prices £691mln bond offering linked to Alexion Pharmaceuticalsacquisition
The notes must be redeemed before the maturity date if the deal doesn’t happen before March 2022 or if it gets scrapped
AstraZeneca's £27.5bn acquisition of Alexion under investigation by competition watchdog
The CMA has opened an invitation to comment until 3 June for parties involved
Coronavirus vaccines: UK hits 60mln doses milestone as new study proves AstraZeneca, Pfizer/BioNTech jabs work against Indian variant
Two doses are required to get strong protection against the new strain
Archive
AstraZeneca and Moderna receive approval for COVID-19 vaccines in Japan
The Vaxzevria jab will be administered in two doses given four to 12 weeks apart
AstraZeneca vaccine up to 90% effective 'real-life data' indicates
Government has said that it is confident the vaccines are effective against the Indian variant.
Heated AGM season is underway as shareholders fight pay hikes for bosses
AstraZeneca, Rio Tinto and Glencore are part of a long list of companies that are facing backlash over remuneration packages
Big chunk of AstraZeneca shareholders vote against boss pay hike but majority still backs it
The pay proposal includes bonuses of £12mln or more
AstraZeneca faces investor backlash after hiking chief executive bonus by £2.3mln
Aviva and Standard Life Aberdeen have voted to block the proposal ahead of Tuesday’s AGM
AstraZeneca posts positive final-stage trial results for lung cancer treatment
The candidate was analysed in combination with platinum-based chemotherapy, or antibody tremelimumab and chemotherapy, compared to chemotherapy alone